source
- Warp Sciences raises $215 million Series A to apply AI in drug building-block designFormer OpenAI head of science Kevin Weil announced the launch of Warp Sciences, a new startup aimed at accelerating the creation of molecular building blocks for drug discovery. The company secure…
- Gilead agrees to pay $1.28 billion upfront to China's PepStar for oral IL-23 inflammation drug candidateGilead Sciences announced a deal with Chinese biotech PepStar Therapeutics to acquire an early-stage oral IL-23 inhibitor. The agreement includes an upfront payment of roughly $1.28 billion for Pe…